title: Insidious dopamine: provocateur or protective agent in Parkinson's disease?
authors.affiliation: Department of Pharmacology, Quillen College of Medicine, East Tennessee State University, Johnson City 37614, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Kostrzewa
authors.forename: R
authors.initials: R
authors.lastname: Brus
authors.forename: J P
authors.initials: JP
authors.lastname: Kostrzewa
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D000978:Antiparkinson Agents; D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species; D007980:Levodopa; D004298:Dopamine